By a GenomeWeb staff reporter
The funding will be used primarily to set up a European multi-center clinical trial for the validation of a molecular test to predict non-response to anti-TNF treatment, in particular Remicade.
Celera names Merriweather as SVP and CFO; TcLand Expression appoints Payne as CBO.
The French firm also said it has received $564,000 in funding for the project.
Patrick Terry, Lisa Wise, James O'Leary
Jack Lord is named president and CEO of Navigenics, while Celera has a new CFO, and Patrick Terry joins the board of directors of TcLand Expression, plus more.
In an against-all-odds twist, a researcher studying exceeding rare FOXG1 mutations discovers her daughter has the syndrome.
An effort by Genomics Medicine Ireland is creating a database of diseases based on the genomics of people in Ireland. It now is looking into the possibility of including Scotland in its work.
In recent weeks, the direct-to-consumer genetics firm has rolled out a health hub where customers can share information concerning 18 common health conditions.
In PLOS this week, new genes associated with prostate cancer risk, genetic patterns in M. bovis, and more.